RVNC logo

Revance Therapeutics (RVNC) Interest Coverage Ratio

RVNC Annual Interest Coverage Ratio

-15.72
+4.87+23.65%

31 December 2023

RVNC Interest Coverage Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RVNC Quarterly Interest Coverage Ratio

-4.44
+1.16+20.71%

30 September 2024

RVNC Quarterly Interest Coverage Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RVNC Interest Coverage Ratio Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.6%+33.6%
3 y3 years+11.7%+90.4%
5 y5 years+99.5%-

RVNC Interest Coverage Ratio High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+64.1%at high+88.7%
5 y5-yearat high+64.1%at high+90.4%
alltimeall time-1456.4%+99.5%-3600.0%+99.8%

Revance Therapeutics Interest Coverage Ratio History

DateAnnualQuarterly
Sept 2024
-
-4.44(-20.7%)
June 2024
-
-5.60(-33.5%)
Mar 2024
-
-8.42(-73.7%)
Dec 2023
-15.72(-23.7%)
-31.96(+377.7%)
Sept 2023
-
-6.69(-45.7%)
June 2023
-
-12.32(+26.0%)
Mar 2023
-
-9.78(-74.2%)
Dec 2022
-20.59(-53.0%)
-37.90(+240.2%)
Sept 2022
-
-11.14(-25.0%)
June 2022
-
-14.86(-54.0%)
Mar 2022
-
-32.32(-17.4%)
Dec 2021
-43.84(+146.3%)
-39.11(-15.6%)
Sept 2021
-
-46.34(+3.0%)
June 2021
-
-45.01(+0.2%)
Mar 2021
-
-44.92(+158.6%)
Dec 2020
-17.80(-99.4%)
-17.37(-2.1%)
Sept 2020
-
-17.75(+34.1%)
June 2020
-
-13.24(-52.4%)
Mar 2020
-
-27.79(-96.5%)
Dec 2018
-3171.00(+1106.3%)
-
Mar 2018
-
-795.30(-60.1%)
DateAnnualQuarterly
Dec 2017
-262.87(+222.5%)
-1993.83(+578.8%)
Sept 2017
-
-293.72(+54.9%)
June 2017
-
-189.60(+35.7%)
Mar 2017
-
-139.70(+18.3%)
Dec 2016
-81.50(+34.2%)
-118.12(+70.6%)
Sept 2016
-
-69.23(-18.6%)
June 2016
-
-85.02(+36.8%)
Mar 2016
-
-62.14(+1.8%)
Dec 2015
-60.74(+1139.6%)
-61.06(+26.8%)
Sept 2015
-
-48.17(-18.7%)
June 2015
-
-59.23(-35.9%)
Mar 2015
-
-92.35(+123.6%)
Dec 2014
-4.90(+99.2%)
-41.30(-31.5%)
Sept 2014
-
-60.30(+23.5%)
June 2014
-
-48.82(+4037.3%)
Mar 2014
-
-1.18(-76.1%)
Dec 2013
-2.46(+143.6%)
-4.94(-79.7%)
Sept 2013
-
-24.31(+5.1%)
June 2013
-
-23.14(+3113.9%)
Mar 2013
-
-0.72(+500.0%)
Dec 2012
-1.01(-33.6%)
-0.12
Dec 2011
-1.52
-

FAQ

  • What is Revance Therapeutics annual interest coverage ratio?
  • What is the all time high annual interest coverage ratio for Revance Therapeutics?
  • What is Revance Therapeutics annual interest coverage ratio year-on-year change?
  • What is Revance Therapeutics quarterly interest coverage ratio?
  • What is the all time high quarterly interest coverage ratio for Revance Therapeutics?
  • What is Revance Therapeutics quarterly interest coverage ratio year-on-year change?

What is Revance Therapeutics annual interest coverage ratio?

The current annual interest coverage ratio of RVNC is -15.72

What is the all time high annual interest coverage ratio for Revance Therapeutics?

Revance Therapeutics all-time high annual interest coverage ratio is -1.01

What is Revance Therapeutics annual interest coverage ratio year-on-year change?

Over the past year, RVNC annual interest coverage ratio has changed by +4.87 (+23.65%)

What is Revance Therapeutics quarterly interest coverage ratio?

The current quarterly interest coverage ratio of RVNC is -4.44

What is the all time high quarterly interest coverage ratio for Revance Therapeutics?

Revance Therapeutics all-time high quarterly interest coverage ratio is -0.12

What is Revance Therapeutics quarterly interest coverage ratio year-on-year change?

Over the past year, RVNC quarterly interest coverage ratio has changed by +2.25 (+33.63%)